Andreas KORDIKOWSKI

Person

Basel, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Crystalline forms of a TLR7/TLR8 inhibitor
- Patent number 12,084,460
- Issue date Sep 10, 2024
- Novartis AG
- Nicole Bieri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of a LTA4H inhibitor
- Patent number 11,993,582
- Issue date May 28, 2024
- Novartis AG
- Andreas Kordikowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl aminopropanol derivatives
- Patent number 11,932,630
- Issue date Mar 19, 2024
- Andreas Kordikowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triaz...
- Patent number 11,891,401
- Issue date Feb 6, 2024
- Novartis AG
- Yudong Cao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for the treatment of parasitic diseases
- Patent number 11,597,733
- Issue date Mar 7, 2023
- Novartis AG
- Nicole Alice Blaquiere
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline isoxazole hydroxamic acid compounds
- Patent number 10,071,973
- Issue date Sep 11, 2018
- Novartis AG
- Jiping Fu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBITOR
- Publication number 20240391938
- Publication date Nov 28, 2024
- Novartis AG
- Nicole BIERI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Heteroaryl Aminopropanol Derivatives
- Publication number 20240199593
- Publication date Jun 20, 2024
- Novartis AG
- Andreas Kordikowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Heteroaryl Aminopropanol Derivatives
- Publication number 20220348566
- Publication date Nov 3, 2022
- Novartis AG
- Andreas Kordikowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF N-(5-(5-((1R,2S)-2-FLUOROCYCLOPROPYL)-1,2,4-OX...
- Publication number 20220194936
- Publication date Jun 23, 2022
- Novartis AG
- Xiaoyang WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF N-(4-FLUORO-3-(6-(3-METHYLPYRIDIN-2-YL)-[1,2,4]TRIAZ...
- Publication number 20220041604
- Publication date Feb 10, 2022
- Novartis AG
- Yudong Cao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF A LTA4H INHIBITOR
- Publication number 20210300897
- Publication date Sep 30, 2021
- Andreas Kordikowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBIT0R
- Publication number 20210206783
- Publication date Jul 8, 2021
- Novartis AG
- Nicole BIERI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
- Publication number 20210115065
- Publication date Apr 22, 2021
- Novartis AG
- Nicole Alice Blaquiere
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE ISOXAZOLE HYDROXAMIC ACID COMPOUNDS
- Publication number 20170355684
- Publication date Dec 14, 2017
- Novartis AG
- Jiping FU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Andreas KORDIKOWSKI

Person

Patents Grantslast 30 patents

Crystalline forms of a TLR7/TLR8 inhibitor

Crystalline forms of a LTA4H inhibitor

Heteroaryl aminopropanol derivatives

Solid forms of N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triaz...

Compounds and compositions for the treatment of parasitic diseases

Crystalline isoxazole hydroxamic acid compounds

Patents Applicationslast 30 patents

CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBITOR

Novel Heteroaryl Aminopropanol Derivatives

Novel Heteroaryl Aminopropanol Derivatives

CRYSTALLINE FORMS OF N-(5-(5-((1R,2S)-2-FLUOROCYCLOPROPYL)-1,2,4-OX...

SOLID FORMS OF N-(4-FLUORO-3-(6-(3-METHYLPYRIDIN-2-YL)-[1,2,4]TRIAZ...

CRYSTALLINE FORMS OF A LTA4H INHIBITOR

CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBIT0R

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

CRYSTALLINE ISOXAZOLE HYDROXAMIC ACID COMPOUNDS